SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study

AIM: To assess the prevalence of metabolic syndrome (MetS) and osteoporosis in patients with prostate cancer (PCa) treated with radical radiotherapy (RT) with or without androgen deprivation therapy (ADT). BACKGROUND: Worldwide, the prevalence of MetS is estimated to range from 20% to 25% of the adu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rep Pract Oncol Radiother
Main Authors: Samper Ots, Pilar Ma, Muñoz García, Julia Luisa, Ríos Kavadoy, Yesika, Couselo Paniagua, Ma Luz, Villafranca Iturre, Elena, Rodríguez Liñán, Milagrosa, Pérez Casas, Ana María, Soria, Rodrigo Muelas, Martínez, Blanca Ludeña, Torrecilla, José López, Giner, Manuel Casaña, Laborda, Almudena Zapatero, García-Salazar, Ma Magdalena Márquez
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4597092/
https://ncbi.nlm.nih.gov/pubmed/26549995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rpor.2015.06.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados